Related Experiment Videos

Identification of binding domains for basic fibroblast growth factor in proteoglycan macrophage colony-stimulating

S Suzu1, F Kimura, H Matsumoto

  • 1Biochemical Research Laboratory, Morinaga Milk Industry Co., Ltd., Kanagawa, Japan.

Insights

Proteoglycan macrophage colony-stimulating factor (PG-M-CSF) binds basic fibroblast growth factor (bFGF) at two distinct sites. These PG-M-CSF binding sites neutralize bFGF

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Protein Interactions

Background:

  • Proteoglycan macrophage colony-stimulating factor (PG-M-CSF) is known to bind basic fibroblast growth factor (bFGF).
  • PG-M-CSF neutralizes the biological activity of bFGF, suggesting specific interaction sites.

Purpose of the Study:

  • To identify the precise binding sites of PG-M-CSF for bFGF.
  • To characterize the functional significance of these binding interactions.

Main Methods:

  • Examination of bFGF binding to overlapping 12-mer peptides representing the putative binding region of PG-M-CSF.
  • Assessment of synthetic peptide inhibition of bFGF binding to other peptides.
  • Evaluation of peptide effects on bFGF-induced and platelet-derived growth factor-induced DNA synthesis in Balb/c 3T3 cells.

Main Results:

  • High-affinity binding of bFGF to PG-M-CSF was detected at two distinct peptide regions: peptides 212-225 and 246-259.
  • Individual synthetic peptides from these regions did not inhibit each other's binding to bFGF.
  • Both identified peptides inhibited bFGF-induced, but not platelet-derived growth factor-induced, DNA synthesis.

Conclusions:

  • PG-M-CSF interacts with bFGF at two specific regions, mediating its biological activity.
  • These findings elucidate the molecular mechanism of PG-M-CSF's bFGF neutralization.
  • The identified peptides represent potential therapeutic targets for modulating bFGF signaling.

Related Concept Videos